Questions Linger After FDA's Lab-Developed Tests Proposal
On Sept. 29, and as widely anticipated, the U.S. Food and Drug Administration announced the publication of a proposed rule to clarify that lab-developed tests, or LDTs, are medical devices subject...To view the full article, register now.
Already a subscriber? Click here to view full article